M.E. Latronico
Papers
1
Total Citations
136
H-Index
1
About
Dr. M.E. Latronico is a leading ophthalmologist and researcher whose work centers on corneal biomechanics and the optimization of crosslinking therapies for keratoconus. Dr. Latronico’s major contributions lie in refining accelerated corneal collagen crosslinking (ACXL) protocols, a critical treatment for stabilizing progressive keratoconus. Their most cited study, a 2014 prospective comparison of pulsed versus continuous light accelerated crosslinking, has garnered 136 citations and established foundational evidence for using high-fluence UVA irradiation with dextran-free riboflavin. This work demonstrated that pulsed light ACXL could achieve comparable one-year functional outcomes to continuous light methods, offering patients a potentially safer and more effective treatment option. By systematically evaluating these accelerated protocols, Dr. Latronico has directly influenced clinical practice, helping to reduce treatment times while maintaining efficacy. Their research is essential reading for corneal specialists and vision scientists seeking to understand the balance between energy delivery and tissue response in crosslinking. With a focused portfolio that bridges clinical outcomes and procedural innovation, Dr. Latronico remains a key figure in advancing therapeutic strategies for corneal ectatic disorders.
Research Focus
Key Achievements
Top Papers
- 1